amsacrine has been researched along with Prostatic Neoplasms in 3 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Natale, RB | 1 |
| Yagofa, A | 1 |
| Watson, RC | 1 |
| Drelichman, A | 1 |
| Decker, DA | 1 |
| Al-Sarraf, M | 1 |
| Dhabuwala, CB | 1 |
| Yamazaki, H | 1 |
| Dilworth, A | 1 |
| Myers, CE | 1 |
| Sinha, BK | 1 |
3 other studies available for amsacrine and Prostatic Neoplasms
| Article | Year |
|---|---|
Phase II trial of AMSA in prostatic cancer.
Topics: Adult; Aged; Aminoacridines; Amsacrine; Antineoplastic Agents; Drug Evaluation; Humans; Male; Middle | 1982 |
M-AMSA in disseminated prostatic carcinoma: a phase II study.
Topics: Adult; Aged; Aminoacridines; Amsacrine; Antineoplastic Agents; Drug Evaluation; Humans; Leukopenia; | 1982 |
Suramin inhibits DNA damage in human prostate cancer cells treated with topoisomerase inhibitors in vitro.
Topics: Amsacrine; Camptothecin; Cell Survival; Chemical Precipitation; DNA Damage; Dose-Response Relationsh | 1993 |